Human B lymphocytes express the p75 component of the interleukin 2 receptor.

[1]  S. Kishimoto,et al.  Expression and the functional role of a p70/75 interleukin 2-binding molecule in human B cell. , 1988, Journal of immunology.

[2]  D. Mckay,et al.  Three-dimensional structure of interleukin-2. , 1987, Science.

[3]  N. Heerema,et al.  B-cell growth factor receptor expression and B-cell growth factor response of leukemic B cell precursors and B lineage lymphoid progenitor cells , 1987 .

[4]  W. Greene,et al.  Contrasting interleukin 2 binding properties of the alpha (p55) and beta (p70) protein subunits of the human high-affinity interleukin 2 receptor , 1987, The Journal of experimental medicine.

[5]  W. Greene,et al.  Direct activation of human resting T cells by IL 2: the role of an IL 2 receptor distinct from the Tac protein. , 1987, Journal of immunology.

[6]  T. Diamantstein,et al.  The mouse high affinity IL 2 receptor complex. I. Evidence for a third molecule, the putative gamma-chain, associated with the alpha- and/or beta-chain of the receptor. , 1987, Immunobiology.

[7]  D. Kabelitz,et al.  B cell maturation in chronic lymphocytic leukemia. II. Clonal heterogeneity in the response to various B cell activators and recombinant cytokines (rIFN-gamma, rIFN-alpha, rIL2). , 1987, Immunobiology.

[8]  W. Chan,et al.  The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[9]  B. Cullen,et al.  A second human interleukin-2 binding protein that may be a component of high-affinity interleukin-2 receptors , 1987, Nature.

[10]  D. Bevan,et al.  Direct effect of interleukin 2 on chronic lymphocytic leukaemia B cell functions and morphology. , 1987, Clinical and Experimental Immunology.

[11]  T. Waldmann,et al.  Contribution of a p75 interleukin 2 binding peptide to a high-affinity interleukin 2 receptor complex. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[12]  I. Touw,et al.  The proliferative response of B cell chronic lymphocytic leukemia to interleukin 2: functional characterization of the interleukin 2 membrane receptors. , 1987, Blood.

[13]  W. Greene,et al.  Interleukin 2 binding molecule distinct from the Tac protein: analysis of its role in formation of high-affinity receptors. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[14]  W. Greene,et al.  Internalization of interleukin 2 is mediated by the beta chain of the high-affinity interleukin 2 receptor , 1987, The Journal of experimental medicine.

[15]  K. Kato,et al.  Interleukin 2 high-affinity receptor expression requires two distinct binding proteins , 1987, The Journal of experimental medicine.

[16]  T. Waldmann,et al.  Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[17]  B. Cullen,et al.  Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions. , 1986, Science.

[18]  A. Porwit,et al.  Malignant B-cells have receptors for and respond to interleukin-2 , 1986, Medical oncology and tumor pharmacotherapy.

[19]  T. Waldmann.  The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes. , 1986, Science.

[20]  J. Quesada,et al.  Growth factor-mediated tumor cell proliferation in hairy cell leukemia , 1985, The Journal of experimental medicine.

[21]  A. Fauci,et al.  Human B lymphoma cell line producing B cell growth factor. , 1985, The Journal of clinical investigation.

[22]  A. Fauci,et al.  Interleukin 2 receptors on human B cells. Implications for the role of interleukin 2 in human B cell function , 1985, The Journal of experimental medicine.

[23]  T. Miyawaki,et al.  Immunohistologic localization and immune phenotypes of lymphocytes expressing Tac antigen in human lymphoid tissues. , 1984, Journal of immunology.

[24]  T. Waldmann,et al.  Expression of interleukin 2 receptors on activated human B cells , 1984, The Journal of experimental medicine.

[25]  T. Boone,et al.  Stimulation of immunoglobulin secretion in human B lymphocytes as a direct effect of high concentrations of IL 2. , 1984, Journal of immunology.

[26]  G. Crabtree,et al.  Molecular cloning and expression of cDNAs for the human interleukin-2 receptor , 1984, Nature.

[27]  T. Honjo,et al.  Molecular cloning of cDNA encoding human interleukin-2 receptor , 1984, Nature.

[28]  J. Lowenthal,et al.  Activated B cells express receptors for, and proliferate in response to, pure interleukin 2 , 1984, The Journal of experimental medicine.

[29]  W. Greene,et al.  Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen , 1984, The Journal of experimental medicine.

[30]  M. Tsudo,et al.  Expression of Tac antigen on activated normal human B cells , 1984, The Journal of experimental medicine.

[31]  G. H. Reem,et al.  Interleukin 2 regulates expression of its receptor and synthesis of gamma interferon by human T lymphocytes. , 1984, Science.

[32]  T. Waldmann,et al.  Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[33]  A. Fauci,et al.  Differential sensitivity of human B cell subsets to activation signals delivered by anti-mu antibody and proliferative signals delivered by a monoclonal B cell growth factor , 1983, The Journal of experimental medicine.

[34]  T. Leanderson,et al.  B-cell growth factor: distinction from T-cell growth factor and B-cell maturation factor. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[35]  D. Vaux,et al.  Proliferation and differentiation of single hapten-specific B lymphocytes is promoted by T-cell factor(s) distinct from T-cell growth factor. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[36]  T. Waldmann,et al.  A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. , 1981, Journal of immunology.

[37]  C. Begley,et al.  Primary human myeloid leukemia cells: comparative responsiveness to proliferative stimulation by GM-CSF or G-CSF and membrane expression of CSF receptors. , 1987, Leukemia.

[38]  A. Fauci,et al.  Direct effect of interleukin 2 on the differentiation of human B cells which have not been preactivated in vitro , 1985, European journal of immunology.

[39]  C. March,et al.  Cloning, sequence and expression of human interleukin-2 receptor , 1984, Nature.